PFM Health Sciences Revenue and Competitors
Estimated Revenue & Valuation
- PFM Health Sciences's estimated annual revenue is currently $3.5M per year.
- PFM Health Sciences's estimated revenue per employee is $158,900
Employee Data
- PFM Health Sciences has 22 Employees.
- PFM Health Sciences grew their employee count by 16% last year.
PFM Health Sciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Compliance Officer | Reveal Email/Phone |
2 | Partner | Reveal Email/Phone |
PFM Health Sciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 0 | N/A | N/A | N/A |
#2 | $345.7M | 1065 | 21% | $8.7M | N/A |
#3 | $27.5M | 121 | 14% | N/A | N/A |
#4 | $6.7M | 37 | 12% | N/A | N/A |
#5 | $8.2M | 45 | 0% | N/A | N/A |
#6 | $146.1M | 515 | 2% | N/A | N/A |
#7 | $628.9M | 1979 | -88% | N/A | N/A |
#8 | $88.2M | 311 | 4% | N/A | N/A |
#9 | $27.5M | 121 | -4% | N/A | N/A |
#10 | $12.1M | 59 | -8% | N/A | N/A |
What Is PFM Health Sciences?
N/A
Total Funding
22
Number of Employees
$3.5M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PFM Health Sciences News
2022-04-13 - institutional investors of Caribou Biosciences, Inc. (NASDAQ:CRBU) must be
disappointed after last week's 9.4% drop
PFM Health Sciences, LP is currently the largest shareholder, with 6.7% of shares outstanding. The second and third largest shareholders are...
2022-03-22 - Artificial Disc Market to Expand at a Considerable CAGR of ...
KG, Aditus Medical, Evospine GmbH, Prodorth Spine, SIGNUS Medizintechnik ... Aesculap, Inc, B. Braun Company, Exsurco Medical, PFM Medical,...
2022-03-22 - Medtech's top 10 money raisers of 2021
Caris Life Sciences is no stranger to VC megarounds, ... Watrium, Cambridge Innovation Capital, PFM Health Sciences, GE Healthcare.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.1M | 22 | 0% | N/A |
#2 | $3.1M | 22 | -8% | N/A |
#3 | $1.7M | 22 | -33% | $173M |
#4 | $2.2M | 22 | 5% | N/A |
#5 | $1.8M | 22 | -27% | N/A |